Company Filing History:
1 out of 973 
1 out of 878 
Years Active: 2014
Title: Shama Nasim: Innovator in Antileukemic Research
Introduction
Shama Nasim is a prominent inventor based in Lexington, KY (US). She has made significant contributions to the field of medicinal chemistry, particularly in the development of antileukemic agents. Her innovative work has the potential to impact cancer treatment and improve patient outcomes.
Latest Patents
Shama Nasim holds 1 patent for her invention titled "Melampomagnolide B derivatives as antileukemic and cytotoxic agents." This patent discloses Melampomagnolide B as a new antileukemic sesquiterpene. Additionally, a biotin-conjugated derivative of Melampomagnolide B was prepared to elucidate its mechanism of action. The patent also includes prodrugs of Melampomagnolide B, showcasing her innovative approach to cancer therapy.
Career Highlights
Throughout her career, Shama Nasim has worked with esteemed institutions such as the University of Rochester and the University of Kentucky Research Foundation. Her research has focused on developing novel therapeutic agents that can combat leukemia and other forms of cancer.
Collaborations
Shama has collaborated with notable colleagues, including Peter Anthony Crooks and Craig T. Jordan. These partnerships have enriched her research and contributed to the advancement of her innovative projects.
Conclusion
Shama Nasim's work in the field of antileukemic research exemplifies her dedication to improving cancer treatment through innovation. Her contributions are paving the way for future advancements in medicinal chemistry.